Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial.

Autor:	Symonds, R Paul1 rps8@le.ac.uk, Gourley, Charlie2, Davidson, Susan3, Carty, Karen4, McCartney, Elaine4, Rai, Debbie4, Banerjee, Susana5, Jackson, David6, Lord, Rosemary7, McCormack, Mary8, Hudson, Emma9, Reed, Nicholas10, Flubacher, Maxine11, Jankowska, Petra12, Powell, Melanie13, Dive, Caroline14, West, Catharine M L15, Paul, James4
Zdroj:	Lancet Oncology. Nov2015, Vol. 16 Issue 15, p1515-1524. 10p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu